Reported Adverse Drug Reactions in Infants: A Nationwide Analysis in Malaysia

Rosliana Rosli1, Ahmad Fauzi Dali1, Noorizan Abd Aziz1

  • 1Faculty of Pharmacy, Universiti Teknologi MARA Puncak Alam, Malaysia.

Frontiers in Pharmacology
|February 28, 2017
PubMed

Insights

Spontaneous reporting of adverse drug reactions (ADRs) in infants under 2 years old in Malaysia revealed that antibacterials, particularly penicillins, were the most common cause of skin reactions. Most reactions were mild and occurred within 24 hours.

Area of Science:

  • Pharmacovigilance and Drug Safety
  • Pediatric Pharmacology
  • Clinical Toxicology

Background:

  • Spontaneous adverse drug reactions (ADRs) reporting is crucial for understanding drug safety in infants, as clinical trials primarily focus on adult populations.
  • Evaluating ADRs in children under 2 years old is essential due to their unique physiological characteristics and developing systems.
  • Malaysia's national pharmacovigilance database provides a valuable resource for analyzing pediatric ADR trends.

Purpose of the Study:

  • To evaluate spontaneously reported ADRs in children under 2 years of age using WHO Adverse Reaction Terminology.
  • To identify common drugs associated with ADRs in this vulnerable pediatric population.
  • To characterize the nature and outcomes of ADRs in Malaysian infants.

Main Methods:

  • Retrospective analysis of ADR data for children under 2 years old from Malaysia's QUEST2 System (2000-2013).
  • Analysis included age, gender, reporting source, reporter type, suspected medicines, and ADR characteristics (category, onset, severity, outcomes).
  • Data from 907 ADR reports (1312 ADRs) were analyzed.

Main Results:

  • 14.0% of reported ADRs involved children under 2 years old.
  • Skin appendage disorders were the most common ADRs (60.1%), with rash and maculopapular rash being frequent symptoms.
  • Systemic antibacterials (58.8%), especially penicillins and other β-Lactam Antibacterials (>40%), were the most frequent drug culprits. Most ADRs were mild skin reactions occurring within 24 hours.

Conclusions:

  • Systemic antibacterials are the primary cause of ADRs in Malaysian children under 2 years, predominantly manifesting as skin reactions.
  • The study highlights rare cutaneous ADRs in this age group, emphasizing their significance as a cause of harm.
  • Findings underscore the importance of pharmacovigilance for monitoring drug safety in pediatric populations.

Related Concept Videos

Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
3.2K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
66
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
342
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.9K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
615
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
575